poseida.com Open in urlscan Pro
35.230.96.204  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Company
   * Our Story & Team
     * Who We Are
     * Leadership
     * Board of Directors
     * Scientific Advisory Boards
   * More Information
     * Corporate Contact
     * Partners & Collaborators
     * Press Releases
 * Science
   * Get Started
     * Platforms
     * Pipeline
     * Publications
   * Explore
     * piggyBac®
     * Cas-CLOVER™
     * Gene Delivery
     * CAR-T Tools
     * CAR-T Therapies
     * Gene Therapies
 * Patients
   * For Patients
     * Our Approach
     * Expanded Access
   * Explore
     * Our CAR-T Therapies
     * Our Gene Therapies
     * Clinical Trials
 * Investors and Media
   * Overview
     * Corporate Profile
     * Press Releases
     * Poseida News Center
     * Events & Presentations
     * Publications
   * Financials & Filings
     * SEC Filings
     * Quarterly Results
   * Stock Information
     * Stock Quote & Chart
     * Email Alerts
     * Covering Analysts
   * Corporate Governance
     * Documents & Charters
     * Board of Directors
     * Committee Composition
   * IR Contact
 * Careers
   * Life at Poseida
     * Join Our Team
     * Our Culture
     * Benefits
   * Explore
     * Jobs


THE NEXT WAVE OF
CELL & GENE THERAPIES
WITH THE CAPACITY TO CURE

At Poseida Therapeutics, we are moving closer every day to transforming the
treatment of life-threatening diseases. Our gene engineering technologies
represent the next wave of innovation, giving new hope to patients with cancers
and genetic disease.


WHAT IF


SINGLE TREATMENT CURES

We’re changing the very model of disease treatment. Our piggyBac DNA
Modification System enables us to target single treatment cures. In our CAR-T
oncology programs we can reshape the composition of therapies to feature a
higher degree of stem cell memory T cells. In our gene therapy programs we
aspire to develop single treatment cures. We believe our novel approach can
drive better patient outcomes with less toxicity across our pipeline.


ACCESSIBLE TREATMENT

Disease does not discriminate, but access to treatment often does, especially
new, life-saving, potentially breakthrough cell and gene therapies. Our mission
at Poseida is to develop the science to enable accessible and transformational
treatment for all – safe, affordable, and standardized.

“The incredible teamwork and collaboration at Poseida help us solve complex
problems associated with cell and gene therapy.”


Nick G .

POSEIDA EMPLOYEE




OFF-THE-SHELF THERAPIES

At Poseida, we’re harnessing the power of the immune system to develop safer,
more effective, accessible, and affordable treatments. In CAR-T, we are striving
for dramatically greater access to treatments by producing them from universal
donor cells – an off-the-shelf approach that will expand capacity and increase
access while lowering costs.


CAR-T FOR SOLID TUMORS

Early CAR-T treatments have been focused on liquid tumors – blood cancers in the
lymphoma and leukemia families. The unique benefits of Poseida’s piggyBac DNA
Modification System and other technologies are at the core of moving CAR-T into
treating solid tumors, such as prostate cancer. CAR-T was the first revolution.
Extending it to solid tumors is the next one, and we are proud to be leading it.


WHAT NOW

“CAR-T has the potential to make a great difference, giving patients an
opportunity to get treatment and then have life without drugs or side effects.”


CAITLIN C., M.D.

HEMATOLOGIC ONCOLOGIST




WHAT NEXT


GENE THERAPIES

Poseida is utilizing our proprietary tools to develop next-generation solutions
including liver-directed gene therapies utilizing nanoparticle technology, which
are showing promise in preclinical data in the continued pursuit of single
treatment cures beyond oncology.


EXPANDED CAPABILITIES

At Poseida, we don’t see problems as insurmountable. Instead, we work through
challenges and generate the additional capabilities and tool sets to overcome
them. Our robust gene delivery and best-in-class gene editing tools are examples
of how we are continually expanding the benefits of our platforms to tackle the
most complex problems.

“We are developing therapies to revolutionize the treatment of cancers and
genetic disease in pursuit of single treatment cures.”


Eric M. Ostertag, M.D., Ph.D.

POSEIDA EXECUTIVE CHAIRMAN




INTERESTED IN MORE DETAILS?

Let us know how we can help.


 * Company
   * Our Story & Team
     * Who We Are
     * Leadership
     * Board of Directors
     * Scientific Advisory Boards
   * More Information
     * Corporate Contact
     * Partners & Collaborators
     * Press Releases
 * Science
   * Get Started
     * Platforms
     * Pipeline
     * Publications
   * Explore
     * piggyBac®
     * Cas-CLOVER™
     * Gene Delivery
     * CAR-T Tools
     * CAR-T Therapies
     * Gene Therapies
 * Patients
   * For Patients
     * Our Approach
     * Expanded Access
   * Explore
     * Our CAR-T Therapies
     * Our Gene Therapies
     * Clinical Trials
 * Investors and Media
   * Overview
     * Corporate Profile
     * Press Releases
     * Poseida News Center
     * Events & Presentations
     * Publications
   * Financials & Filings
     * SEC Filings
     * Quarterly Results
   * Stock Information
     * Stock Quote & Chart
     * Email Alerts
     * Covering Analysts
   * Corporate Governance
     * Documents & Charters
     * Board of Directors
     * Committee Composition
   * IR Contact
 * Careers
   * Life at Poseida
     * Join Our Team
     * Our Culture
     * Benefits
   * Explore
     * Jobs

 * 
 * 
 * 

Copyright © 2022 Poseida Therapeutics, Inc. | All Rights Reserved | Privacy
Policy | Expanded Access Policy
MENU
 * Company
   * Our Story & Team
     * Who We Are
     * Leadership
     * Board of Directors
     * Scientific Advisory Boards
   * More Information
     * Corporate Contact
     * Partners & Collaborators
     * Press Releases
 * Science
   * Get Started
     * Platforms
     * Pipeline
     * Publications
   * Explore
     * piggyBac®
     * Cas-CLOVER™
     * Gene Delivery
     * CAR-T Tools
     * CAR-T Therapies
     * Gene Therapies
 * Patients
   * For Patients
     * Our Approach
     * Expanded Access
   * Explore
     * Our CAR-T Therapies
     * Our Gene Therapies
     * Clinical Trials
 * Investors and Media
   * Overview
     * Corporate Profile
     * Press Releases
     * Poseida News Center
     * Events & Presentations
     * Publications
   * Financials & Filings
     * SEC Filings
     * Quarterly Results
   * Stock Information
     * Stock Quote & Chart
     * Email Alerts
     * Covering Analysts
   * Corporate Governance
     * Documents & Charters
     * Board of Directors
     * Committee Composition
   * IR Contact
 * Careers
   * Life at Poseida
     * Join Our Team
     * Our Culture
     * Benefits
   * Explore
     * Jobs